MD - MEDNAX Inc Stock Price, Fair Value and News

8.24USD+0.11 (+1.35%)Market Closed

Market Summary

USD8.24+0.11

Market Closed

1.35%

MD Stock Price

View Fullscreen

MD RSI Chart

MD Valuation

Market Cap

693.4M

Price/Earnings (Trailing)

-9.82

Price/Sales (Trailing)

0.35

EV/EBITDA

36.92

Price/Free Cashflow

6.14

MD Price/Sales (Trailing)

MD Profitability

EBT Margin

-3.06%

Return on Equity

-8.24%

Return on Assets

-3.26%

Free Cashflow Yield

16.3%

MD Fundamentals

MD Revenue

Revenue (TTM)

2.0B

Rev. Growth (Yr)

0.83%

Rev. Growth (Qtr)

-0.27%

MD Earnings

Earnings (TTM)

-70.6M

Earnings Growth (Yr)

-71.6%

Earnings Growth (Qtr)

103.25%

Breaking Down MD Revenue

Last 7 days

6.6%

Last 30 days

6.3%

Last 90 days

-10.1%

Trailing 12 Months

-43.1%

How does MD drawdown profile look like?

MD Financial Health

Current Ratio

1.72

Debt/Equity

0.72

Debt/Cashflow

0.18

MD Investor Care

Shares Dilution (1Y)

0.46%

Diluted EPS (TTM)

0.61

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2024	2.0B	0	0	0
2023	2.0B	2.0B	2.0B	2.0B
2022	1.9B	2.0B	2.0B	2.0B
2021	1.7B	1.8B	1.8B	1.9B
2020	1.8B	1.8B	1.8B	1.7B
2019	3.0B	2.6B	2.2B	1.8B
2018	3.5B	3.5B	3.5B	3.5B
2017	3.3B	3.3B	3.4B	3.5B
2016	2.9B	3.0B	3.1B	3.2B
2015	2.5B	2.6B	2.7B	2.8B
2014	2.2B	2.3B	2.4B	2.4B
2013	1.9B	2.0B	2.1B	2.2B
2012	1.6B	1.7B	1.8B	1.8B
2011	1.5B	1.5B	1.6B	1.6B
2010	1.3B	1.3B	1.4B	1.4B
2009	0	1.1B	1.2B	1.3B
2008	0	0	0	1.1B

Get all data in R, Python etc through our Historical Stock Data APIs

About MEDNAX Inc

Pediatrix Medical Group, Inc., together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians. The company also provides maternal-fetal care services, including inpatient and office-based clinical care to expectant mothers and unborn babies through affiliated maternal-fetal medicine subspecialists, as well as obstetricians and other clinicians, including maternal-fetal nurse practitioners, certified nurse mid-wives, sonographers, and genetic counselors. In addition, it offers pediatric cardiology care services comprising inpatient and office-based pediatric cardiology care of the fetus, infant, child, and adolescent patient with congenital heart defects and acquired heart disease, as well as adults with congenital heart defects through affiliated pediatric cardiologist subspecialists and other related clinical professionals; and specialized cardiac care to the fetus, neonatal and pediatric patients. Further, the company provides other pediatric subspecialty care services through pediatric subspecialists, such as pediatric intensivists, pediatric hospitalists, pediatric surgeons, and pediatric ophthalmologists, as well as pediatric ear, nose, and throat physicians; and support services in the areas of hospitals, primarily in the pediatric emergency rooms, labor and delivery areas, and nursery and pediatric departments. The company was formerly known as MEDNAX, Inc. and changed its name to Pediatrix Medical Group, Inc. in July 2022. Pediatrix Medical Group, Inc. was founded in 1979 and is based in Sunrise, Florida.

CEO	Dr. James D. Swift M.D.
WEBSITE	pediatrix.com
INDUSTRY	Healthcare Plans
EMPLOYEES	5250

MEDNAX Inc Frequently Asked Questions

What is the ticker symbol for MEDNAX Inc? What does MD stand for in stocks?

MD is the stock ticker symbol of MEDNAX Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of MEDNAX Inc (MD)?

As of Thu Jul 25 2024, market cap of MEDNAX Inc is 684.12 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of MD stock?

You can check MD's fair value in chart for subscribers.

Is MEDNAX Inc a good stock to buy?

The fair value guage provides a quick view whether MD is over valued or under valued. Whether MEDNAX Inc is cheap or expensive depends on the assumptions which impact MEDNAX Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for MD.

What is MEDNAX Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Thu Jul 25 2024, MD's PE ratio (Price to Earnings) is -9.69 and Price to Sales (PS) ratio is 0.34. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. MD PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on MEDNAX Inc's stock?

In the past 10 years, MEDNAX Inc has provided -0.179 (multiply by 100 for percentage) rate of return.